ODDB.org: Open Drug Database

A. Menarini GmbH - Ranexa 500 mg, Retardtabletten

Swissmedic Registration	60533	Sequence	02
Product name	Ranexa 500 mg	Description	Retardtabletten
ATC-Classification	C01EB18	ATC-Description	Ranolazine
Introduction of Sequence	13.04.2010

Composition

ranolazinum 500 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.54 mg, Überzug: macrogolum 3350, poly(alcohol vinylicus), talcum, cera carnauba, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Delayed release tablets

Active Agent	Dose
Ranolazinum	500 mg

BAG: Active Agent	Dose
Ranolazinum	500 mg

Inactive agents	Dose	additional_information
(Flavum)
(Rubrum)
Acidi Methacrylici
Cellulosum Microcristallinum
Cera Carnauba
E 171		color.
E 172		color.
Hypromellosum
Macrogol	3350	Überzug
Magnesii Stearas
Methylis Methacrylatis Polymerisatum
Sodium Hydroxide
Poly(Alcohol Vinylicus)
Pro Compresso Obducto
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
004	30 Tablet(s)			B		Yes
005	60 Tablet(s)	46.31	66.80	B	SL	No
006	100 Tablet(s)	75.73	98.80	B	SL	No

2025	©ywesee GmbH